⌘K

Login Start Free

Home/Filings/5/A/0000899243-22-006325

5/A//SEC Filing

Nguyen Diem 5/A

Accession 0000899243-22-006325

CIK 0001841387other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 8:31 PM ET

Size

5.8 KB

Accession

0000899243-22-006325

Insider Transaction Report

Form 5/AAmended

Period: 2021-12-31

Candel Therapeutics, Inc.CADL

Director

Transactions

Award
Stock Option (Right to Buy)
2021-07-26+28,480→ 28,480 total
Exercise: $8.00Exp: 2031-07-26→ Common Stock (28,480 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable in thirty-six equal monthly installments following July 26, 2021, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

5
doc5a.xml
FORM 5/A SUBMISSION

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1

filerCIK 0001814338

Filing Metadata

Form type: 5/A
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 8:31 PM ET
Size: 5.8 KB

View on SEC.gov